Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol

SpringerPlus

Volumn 4, Issue 1, 2015, Pages 1-8

  Arabi, Yaseen ^a   Balkhy, Hanan ^a   Hajeer, Ali H ^a   Bouchama, Abderrezak ^a   Hayden, Frederick G ^b   Al Omari, Awad ^c   Al Hameed, Fahad M ^d   Taha, Yusri ^e   Shindo, Nahoko ^f   Whitehead, John ^g   Merson, Laura ^h   AlJohani, Sameera ^a   Al Khairy, Khalid ^a   Carson, Gail ⁱ   Luke, Thomas C ^j   Hensley, Lisa ^k   Al Dawood, Abdulaziz ^a   Al Qahtani, Saad ^a   Modjarrad, Kayvon ^l   Sadat, Musharaf ^a   Rohde, Gernot ^m   Leport, Catherine ⁿ   Fowler, Robert ^o,p   more..

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b UNIVERSITY OF VIRGINIA   (United States)

^c ALFAISAL UNIVERSITY   (Saudi Arabia)

^d KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^e King Abdul Aziz Hospital   (Saudi Arabia)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g LANCASTER UNIVERSITY   (United Kingdom)

^h OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

ⁱ CHURCHILL HOSPITAL   (United Kingdom)

^j NAVAL MEDICAL RESEARCH CENTER   (United States)

^k NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^l WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^m MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ UNIVERSITÉ PARIS DESCARTES   (France)

^o UNIVERSITY OF TORONTO   (Canada)

^p SUNNYBROOK RESEARCH INSTITUTE   (Canada)

more..

Author keywords

Convalescent plasma; Genome; Intensive care; MERS CoV; Middle east respiratory syndrome coronavirus; Neutralizing antibodies; Serology; Viral pneumonia

Indexed keywords

EID: 84947763505     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/s40064-015-1490-9     Document Type: Article

References (15)

1. Cheng Y, Wong R, Soo YO et al (2005) Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis 24:44–46
2. Clopper CJ, Pearson ES (1934) the use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26:404–413
3. Drosten C, Meyer B, Muller MA et al (2014) Transmission of MERS-coronavirus in household contacts. N Engl J Med 371:828–835
4. Hung IF, To KK, Lee CK et al (2011) Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 52:447–456
5. Hung IF, To KK, Lee CK et al (2013) Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection. Chest 144:464–473
6. Kong LK, Zhou BP (2006) Successful treatment of avian influenza with convalescent plasma. Hong Kong Med J 12:489
7. Luke TC, Kilbane EM, Jackson JL, Hoffman SL (2006) Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med 145:599–609
8. Mair-Jenkins J, Saavedra-Campos M, Baillie JK et al (2015) The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 211:80–90
9. Müller MA, Meyer B, Corman VM et al (2015) Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis 15:559–564
10. Public Health England (2015) Middle East respiratory syndrome coronavirus (MERS-CoV): clinical management and guidance. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/459835/merscov_for_clinicians_sept2015.pdf
11. The World Health Organization (2015) Guidelines on Assessing Donor Suitability for Blood Donation. http://apps.who.int/iris/bitstream/10665/76724/1/9789241548519_eng.pdf?ua=1. Accessed 22 September 2015
12. WHO Blood Regulators Network (BRN) (2015) Position Paper on Collection and Use of Convalescent Plasma or Serum as an Element in Middle East Respiratory Syndrome Coronavirus Response. http://www.who.int/bloodproducts/brn/BRN_PositionPaperConvPlasmaMERSCoV_March2014.pdf. Accessed 22 September 2015
13. World Health Orgnization (2015) Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/. Accessed 30 September 2015
14. Yeh KM, Chiueh T, Siu LK et al (2005) Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital. J Antimicrob Chemother 56:919–922
15. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814–1820